XOFLUZA — GENENTECH INC, approved 2025-05-30 (NDA210854).
2,189 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.